A large proportion of sickle erythrocytes is removed from the circulation by the macrophages of the reticuloendothelial system. In view of the proposed role for natural antibodies in the destruction of normal senescent erythrocytes, we looked for a possible similarity in the antibodies that bind in situ to senescent and sickle cells. Bound IgG molecules were detected by a highly sensitive rosetting antiglobulin test, using K562 myeloid cells. After separation on Stractan density gradients, the 0.6% most dense (senescent) normal cells and the most dense 40% sickle cells displayed membrane-bound IgG as reflected by the high proportion of rosettes formed. No antibody was found on lowdensity cells of either type. The bound antibodies were readily eluted from both sickle and normal senescent cells by carbohydrates containing a-galactosyl residues. These antibodies appear identical to the recently discovered human natural anti-agalactosyl IgG (anti-Gal), an IgG antibody present in high titers in normal sera. Moreover, affinity-purified anti-Gal interacted specifically with sickle and normal cells depleted of the autologous antibodies. A similar pattern of binding to the various erythrocyte subpopulations was observed when the radiolabeled lectin with anti-a-galactosyl specificity, Bandeiraea simplicifolia, was used. In vitro phagocytosis of normal and sickle erythrocyte subpopulations correlated with the presence of anti-Gal on these cells. The in situ binding of anti-Gal to a large proportion of sickle erythrocytes may reflect an accelerated physiologic aging process by which immune recognition of prematurely exposed a-galactosyl-bearing antigenic sites contributes to shortened cell survival.
Introduction
Direct measurements of erythrocyte survival in patients with sickle cell disease have shown a markedly decreased survival in the range of 10 to 30 d (1) . The increased erythrocyte destruction takes place both intravascularly and extravascularly in the phagocytic cells of the reticuloendothelial system (RES)' (2, 3). 1 . Abbreviations used in this paper: anti-Gal, human natural anti-agalactosyl IgG; BS, Bandeiraea simplicifolia; BSKG, buffered saline containing potassium and glucose; EA, erythrocyte antibody; ISC, irreversible sickle cells; RES, reticuloendothelial system; TPA, 10-0-tetradecanoyl phorbol ester.
Studies have provided evidence that phagocytosis of normal senescent human erythrocytes (4, 5) , thalassemic cells (6) , or erythrocytes infected by malarial parasites (7) can be mediated by relatively small numbers of IgG molecules bound, in vivo, on the erythrocyte surface. In addition, Hebbel and Miller (8) have recently reported the presence of IgG molecules on high density sickle erythrocytes. They also showed that these antibodies induced the in vitro phagocytosis of the sickle cells by bone marrow and lung macrophages. In view of the similarities in the immunoglobulin-mediated phagocytosis of normal senescent erythrocytes and sickle erythrocytes, these investigators suggested that sickle cells may undergo an accelerated process of senescence, qualitatively similar to the aging of normal cells. In other studies, a natural antibody, human natural anti-a-galactosyl IgG (anti-Gal), which shows specificity for the a-galactosyl carbohydrate structure, was shown to bind in situ to high density normal erythrocytes and to thalassemic erythrocytes (9, 10) . This antibody, which constitutes up to 1% of circulating IgG in every normal individual tested, does not recognize the T (Thompson-Friedenreich) antigen, which bears a terminal ,lgalactosyl residue. In addition, anti-Gal recognizes the specific linkage to the penultimate sugar, and binds specifically to Gala(l-3)Gal structures, but not to Gala(1l4)Gal (the P1 antigen epitope) or Gala( l-3)[Fuca( l-2)]Gal (the B blood group antigen) (1 1). Because the high density normal erythrocytes are thought to represent a senescent population (12, 13) , the in situ binding of anti-Gal to these cells could play a role in their removal from the circulation. Our previous studies have indicated that the anti-Gal binding to senescent erythrocytes is mediated through the Fab portion of the antibody molecule (9) , which implies the accessibility of the Fc portion of the bound anti-Gal for recognition by macrophages. To test the possibility that this same antibody might constitute the excess antibody found on sickle cells, we studied antibody binding to normal and sickle cells that had been separated into various age-related subpopulations by density gradient centrifugation (12, 13) . The presence of IgG molecules on normal and sickle erythrocytes, and the antigenic specificity of the antibodies found on these two erythrocyte types were analyzed by using a sensitive rosetting antiglobulin test (8-10, 14, 15) . The results confirmed the presence of excess antibody bound to sickle cells. They further suggested that this antibody is indeed the same natural anti-Gal that binds to, and induces phagocytosis of, high density normal erythrocytes believed to be the senescent cells (4, 5, 12, 13 ( 14, 15) , in a control system of D-positive erythrocytes coated with anti-D antibodies, the proportion of rosettes was found to be related to the amount of bound antibody, in that the percentage of the rosetting K562 cells gradually decreased with increasing dilution of the anti-D serum. When comparing the rosetting and agglutination antiglobulin test in this system, the rosetting test was found to be several-fold more sensitive. Further, the rosetting test is highly specific, since D-negative cells formed no rosettes after incubation with anti-D antibodies (14) . It Isolation ofanti-Galfrom normal serum. This natural IgG antibody with distinct anti-a-galactosyl specificity was isolated from normal AB type human serum by affinity chromatography, as recently described (9) . Briefly, 100-ml volumes of heat-inactivated AB sera were loaded at 370C onto 10-ml melibiose (a-galactosyl-glucoside) Sepharose columns (Sigma Chemical Co.), expressing terminal a-galactosyl residues. As an optional column, the SYNSORB a-Gal (Chembiomed, Edmonton, Alberta, Canada) was used. The antibodies that were retained on the column after extensive washing (50 volumes) were eluted by 0.5 M melibiose for 2 h at 370C. The carbohydrate was then removed by repeated dialysis against large volumes of PBS, and the anti-Gal IgG molecules were concentrated, employing a protein A Sepharose column (Sigma Chemical Co.) that binds IgG molecules via the Fc moiety. The antibodies were finally eluted from this column in a 5-ml volume of glycine-HCI buffer, pH 2.6, buffered, and dialyzed against PBS.
Binding ofBandeiraea simplicifolia (BS) lectin to density-separated erythrocyte subpopulations. The BS lectin is a plant lectin that was found to bind to various cell membrane glycoconjugates bearing terminal Gala(l-3)Gal residues, including human B blood type erythrocytes (17, 18) . The lectin, purchased from Vector Laboratories, Inc. (Burlingame, CA), was radiolabeled with 125I using Bolton-Hunter reagent (New England Nuclear, Boston, MA). The specific activity obtained was 10' cpm/ Mg. The lectin was brought to a concentration of 100 ytg/ml in balanced salt solution. The labeling procedure did not affect the binding capacity of the lectin, since both the original and the labeled BS agglutinated rabbit erythrocytes, which bear an abundance of a-galactosyl residues (1 1), down to a concentration of 0.05 gg/ml. For erythrocyte labeling, 10-td aliquots containing I gg "2'I-BS lectin were added to triplicate pelleted samples of 50 X 10' type 0 erythrocytes. For assessment of nonspecific binding, the BS was added in a solution of 0.1 M melibiose (a-galactosyl-glucoside). This carbohydrate prevents specific binding of BS to galactosyl residues. After incubation at 37°C for 60 min, the erythrocyte suspensions were washed five times with PBS and transferred to new tubes for counting in a gamma counter. Specific labeling was calculated by subtracting cpm obtained in suspensions with melibiose from the cpm obtained in suspensions containing only the lectin.
In vitro erythrophagocytosis assay. To determine whether the presence of bound antibody promoted erythrophagocytosis, an in vitro phagocytosis assay was used, employing monolayer cultures of macrophages prepared from peripheral blood monocytes. Mononuclear cells obtained from heparinized blood by Ficoll-Hypaque sedimentation were washed, brought to a concentration of 2 X 10' in I ml in RPMI 1640 (Gibco, Grand Island, NY), and supplemented with 2% heat-inactivated fetal calf serum. The cells were plated in 0.2-ml flat-bottomed microwells (Nunc, Denmark). After 180-min incubation at 37°C, the nonadherent cells were removed, and the medium was replaced. Differentiation of the remaining adherent cells into phagocytic macrophages was promoted by incubation for 4-7 d in RPMI 1640 medium containing 1 ug/ml 10-0-tetradecanoyl phorbol ester (TPA) (19) . These cells displayed characteristics of macrophages, including phagocytosis of latex particles, Fc membrane receptors, and esterase staining. The phagocytosis assay was carried out according to the assay described by Kay (4). Erythrocytes (10'/ml) in 0.2-ml aliquots were incubated in triplicate with the macrophage monolayers for 20 h. Erythrocytes that remained after this incubation were then counted in a hemocytometer, and the percentage phagocytized was determined, according to the formula (a -b)/a X 100;
where a is the concentration of erythrocytes in control wells, and b is the concentration of erythrocytes in macrophage-containing wells. Due to the limits of this assay, values of <5% were regarded as background phagocytosis.
Results
Distribution ofnormal and sickle erythrocytes in a discontinuous Stractan gradient. As has been widely observed, the distributions of normal and sickle cells on the density gradients were substantially different from one another (Figs. 1, 2) . In general, the sickle cell samples contained many more cells in the high density region of the gradients than did normal samples. The ISC were concentrated in the most dense bottom subpopulation (fraction VI). Although the densest cell populations were usually relatively depleted of reticulocytes, an occasional sample showed a substantial number of reticulocytes in even the most dense populations.
In addition to the greater abundance of very dense cells, the sickle cell samples also contained a low density population of cells not generally found in normal cell samples. The cells in this low density sickle population were not all reticulocytes. In fact, the reticulocyte percentages were sometimes lower than in the adjacent, higher density population that corresponded in density to the least dense normal populations. In addition, although the vast majority of ISC were found at high density positions, this lowest density population occasionally showed a slight elevation in the percentage of ISC, as compared with the other low density, ISC-poor populations.
Demonstration of IgG antibodies on normal and sickle erythrocytes. Density-separated erythrocytes from 10 normal individuals and 25 sickle cell anemia patients were assayed for bound IgG antibodies by the rosetting antiglobulin test. In the normal samples, no rosettes were found in fractions I-IV (for corresponding densities, see Fig. 1 ), which contained >98% of the red cell population (Fig. 2) (9, 10) . To test the possibility that antibodies that bind to sickle cells and mediate the rosette formation had the same anti-a-galactosyl specificity, elution experiments with various carbohydrates were performed, using cell populations that contained the bound antibodies, as indicated by the high proportion of rosette formation. As can been seen in Table I , the rosette formation by the sickle erythrocytes, as well as by the normal erythrocytes, was greatly decreased after incubation with 100 mM galactose and to an even larger extent with the carbohydrates that contained a-galactosyl residues, a-methyl galactoside, and melibiose (a-galactosyl-glucoside). In contrast, lactose ([B-galactosyl-glucoside), glucose, and mannose were only marginally effective in reducing rosette formation by both types of cells. In particular, ($-methyl galactoside was much less effective than a-methyl galactoside or free galactose. Moreover, additional experiments showed that the natural anti-Gal isolated from normal AB sera readily bound to both senescent normal and sickle erythrocytes, when the cells were first incubated with melibiose (Table II) . The binding of the anti-Gal to these cells represented a specific recognition of a-galactosyl antigenic epitopes, as indicated by the selective inhibition of the interaction in the presence of melibiose, but not lactose (Table II) (Figs. 3 A and B) . The rosette proportion after incubation with anti-Gal (Table II, Fig. 3 ) was usually somewhat higher than that observed in the original subpopulation, but this increase was not statistically significant. In vitro phagocytosis ofnormal and sickle erythrocytes bearing the anti-Gal IgG. The relevance of the anti-Gal antibody in mediating the recognition of senescent normal and pathologic erythrocytes was assessed using in vitro phagocytosis experiments. Whereas considerable patient-to-patient variations were noted, the pattern observed was similar in all patients. The data of a representative normal individual, and that of a sickle cell patient are presented in Fig. 3 residues on these cells. To obtain independent evidence for the exposure of such a carbohydrate entity, we assayed the various subpopulations oftype 0 normal and sickle erythrocytes for the binding of the '25I-BS lectin, which specifically binds to Gala(l-3) residues ofglycoconjugates (11, 17, 18) . As described in Methods, this assay was performed after eluting any autologous anti-Gal by incubation of the erythrocytes with melibiose. The pattern of lectin binding in both normal and sickle cells was closely similar to that of the anti-Gal. That is, only 0.5-1% of the high density normal erythrocyte fraction VI exhibited specific binding, whereas the BS lectin interacted with fractions IV, V, and VI of sickle cells (Fig. 4) . The observed binding on all of these populations corresponded to 500-1,000 BS lectin molecules per erythrocyte. In patients with high proportions of ISC (>25%), no specific binding of the BS could be detected in the high density erythrocyte populations (not shown).
Discussion
Our observations indicate that a large proportion ofsickle erythrocytes with a density higher than 1.094 g/ml bind the natural anti-Gal in vivo. We assume that this represents the same phenomenon reflected in previous observations of bound antibody in high density sickle cell subpopulations (8 a recent study by Petz et al. (20) , in which bound IgG antibodies were found in only 70% of a larger group of patients. It may be that in these patients, erythrocytes are destroyed at an early stage by a nonimmunologic mechanism, before they bind detectable antibody. By studying the effectiveness of various carbohydrates in eluting the antibody bound to the sickle cells, we were able to determine its antigenic specificity. As we had previously found for high density normal cells and for thalassemic cells (9, 10) , the antibody binding showed a distinct specificity for the a-galactosyl anomeric structure. This was shown in two ways: first, the antibody could be specifically eluted from the sickle cells by carbohydrates that contained an a-galactosyl moiety, but not by other carbohydrates, including f3-galactosyl oligosaccharides.
Second, cells from which the antibody had been eluted were then able to bind the anti-Gal, previously shown to bind specifically to a-galactosyl residues (1 1). The presence of anti-agalactosyl antibody in all normal sera studied was also recently demonstrated by other investigators. Bird and Roy (21) and Lalezari et al. (22) found anti-melibiose antibodies in normal sera, and Suzuki and Naiki (23) showed the binding of a natural IgG antibody to the Gala(ll3)Gal containing rabbit ceramide pentahexoside. In our studies, incubation of antibody-depleted higher density cell subpopulations with affinity-purified anti-Gal resulted in a small, but consistent increase in rosette formation as compared with the original subpopulations. This may have been the result ofthe selection of high affinity anti-Gal antibodies in the course ofthe affinity chromatography purification. In these experiments, as before, the binding was specifically inhibited in the presence of melibiose.
The small number of binding sites for antibody, on both normal and sickle cells, complicates identification of the molecules on which the antigenic site resides. Petz (27) . It is not yet clear whether the site to which the natural anti-Gal binds is the same site that has been studied by these other investigators, or whether antibodies with other specificities bind also to normal senescent and pathologic erythrocytes. Further work is needed to resolve these questions. (28) . Further analysis indicated that the BS lectin interacts specifically with Gala( 1-)3) residues on various membrane molecules, as well as soluble glycoproteins (11, 17, 18) . In the present study, binding of the 1251I-labeled lectin to type 0 erythrocytes paralleled that observed with the purified anti-Gal. That is, BS lectin bound to the <1% most dense normal cells, and to the 30-40% sickle cells in fractions IV, V, and VI. The number of a-galactosyl residues, as estimated from the lectin binding, was less than 1,000 per cell, on the average. This is consistent with estimates of antibody binding obtained previously (4, 20, 24 Perhaps more elusive than the identity ofthe anti-Gal binding site is the process by which the antigen exposure occurs. We have previously found that when low density normal cells lacking antibody binding sites are treated with pronase, they develop the capacity to bind anti-Gal (9). Thus, proteolytic cleavage of protein components on the cell surface could provide a means of antigen exposure. Since macrophages are known to secrete proteases (29), prolonged or repeated passage of erythrocytes through areas where macrophages are concentrated, such as the organs of the reticuloendothelial system, could provide an in vivo mechanism for cumulative proteolytic alteration ofthe cell surface. If such a process occurs in vivo, the impaired deformability ofsickle cells might result in their detention in such areas, accelerating and augmenting the appearance of the putative senescence antigen. Certainly, other mechanisms for antigen exposure, such as oxidative damage to the membrane, or some sickling-associated damage, are also possible.
Further studies are needed to determine the identity of the binding site for anti-Gal and the mechanism of its exposure in both normal senescent and sickle cells. Nevertheless, the presence of the same antibody on both types of cells, and its effect in inducing their phagocytosis, suggest that a normal physiologic process for the removal of senescent erythrocytes contributes significantly to the destruction of sickle erythrocytes.
